People with obesity may have lower work productivity due to increased risk of illness, contributing to increased costs for employers, according to industry-supported research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting, in Chicago, Ill.
US argues that AstraZeneca’s IRA suit ‘fares no better than the others’
The Department of Justice on Wednesday took a crack at dismantling AstraZeneca’s lawsuit over the selection of its type 2 diabetes drug Farxiga (dapagliflozin) for